CMAB vs IMAB in Metastatic Prostate Cancer

This study has been withdrawn prior to enrollment.

Sponsor:

Information provided by:

AstraZeneca

ClinicalTrials.gov Identifier:

NCT00255268

First received: October 26, 2005

Last updated: August 24, 2007

Last verified: August 2007

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given